psychotherapy

ketamine

Ketamine is related to psychotherapy as it is identified as a psychedelic substance used within the context of therapeutic practices, as documented in the 2022 Frontiers in Psychology publication [1]. — 14 supporting facts

Montreal model

Justification not yet generated — showing supporting facts

• The authors of the Montreal model report that a brief course of ketamine evokes psychological dynamics that resemble an accelerated short-term psychotherapy more closely than a course of electroconvulsive therapy (ECT).
• The Montreal model utilizes concomitant psychotherapy, which allows patients to continue conventional psychotherapy sessions semi-independently of the ketamine treatment process at regular or as-needed frequencies.
• The Montreal model requires patients to engage in at least one hour of weekly evidence-based psychotherapy, beginning at least two weeks before the initiation of ketamine treatments.
• The Montreal model of ketamine treatment integrates neurobiological and psychological benefits, frames psychoactive effects as opportunities for experiential learning, emphasizes the importance of "set and setting," and utilizes subanesthetic dosages of 0.5–1.0 mg/kg with clinicians present and concomitant psychotherapy.
• The Montreal model combines structured psychiatric care and concomitant psychotherapy with six ketamine infusions, which are administered with psychedelic-inspired nonpharmacological adjuncts such as rolling preparative and integrative psychological support.
• The Montreal model for ketamine treatment seeks to enhance patient engagement in evidence-based psychotherapy by leveraging ketamine's pro-cognitive and anti-suicide effects, as well as the psychological experiences of dosing sessions.
• The Montreal model maintenance phase for treatment-resistant depression (TRD) consists of three forms: medication/neurostimulation, concomitant psychotherapy, and maintenance ketamine treatments.
• The Montreal model for ketamine treatment does not mandate a specific type of psychotherapy, but instead requires the use of any evidence-based approach, such as Cognitive Behavioral Therapy (CBT) or Acceptance and Commitment Therapy (ACT), that the patient is willing to pursue.
• The Montreal model clinical team observed that ketamine treatment differs from electroconvulsive therapy (ECT) because termination of treatment is a critical consideration in psychotherapy, whereas it is generally only a subject of interest in psychiatry.
• The Montreal model for ketamine treatment preparation involves nine specific goals: (1) establishing a treatment frame, (2) cultivating a therapeutic alliance, (3) psychoeducation and management of expectations, (4) determining behavioral treatment goals, (5) optimizing medications, (6) framing the ketamine experience, (7) trial mindfulness exercise, (8) music discussion, and (9) arranging for concomitant psychotherapy.

anxiety disorders

Psychotherapy is a primary clinical intervention for anxiety disorders, as evidenced by its role as an accepted treatment [1] and its proven effectiveness in alleviating symptoms {fact:2, fact:3}. Specific modalities like cognitive-behavioral therapy are highly recommended for these conditions {fact:5, fact:7}, and combined treatment protocols are frequently utilized to improve long-term outcomes {fact:4, fact:6, fact:8}. — 8 supporting facts

cognitive-behavioral therapy

Cognitive Behavioral Therapy is a specific, structured form of psychotherapy as evidenced by its classification in [1] and its role as a widely studied treatment option within the broader field of psychotherapy in [2]. It is frequently cited as an evidence-based approach for treating conditions like depression and anxiety in [3], [4], and [5]. — 7 supporting facts

depression

Depression and psychotherapy are linked as the primary condition and treatment intervention evaluated in clinical research, as evidenced by studies examining the efficacy of psychotherapy for depression [1], [2], and [3]. Furthermore, the two concepts are connected through the investigation of how pharmacological interventions like ketamine may facilitate the effectiveness of psychotherapy in treating depression [4], [5]. — 6 supporting facts

generalized anxiety disorder

Psychotherapy is a primary treatment modality for generalized anxiety disorder, often used as a first-line option either alone or in combination with medication as described in [1], [2], [3], and [4]. Clinical evidence indicates that psychotherapy is highly effective for this condition, with efficacy comparable to medication [1], [5]. — 6 supporting facts

anxiety

Psychotherapy is a primary intervention for anxiety, as evidenced by its role in reducing rebound symptoms [1] and the use of Cognitive Behavioral Therapy to address the negative thought patterns that contribute to anxiety {fact:2, fact:3}. Furthermore, anxiety is categorized as a psychological distress term in clinical research regarding therapeutic interventions [2]. — 4 supporting facts

treatment-resistant depression

Justification not yet generated — showing supporting facts

• A 2018 Cochrane review of psychotherapy for treatment-resistant depression, which analyzed six trials involving 698 participants, concluded that while various approaches like Cognitive Behavioral Therapy (CBT) have high acceptability, they provide only modest improvements.
• The Montreal model maintenance phase for treatment-resistant depression (TRD) consists of three forms: medication/neurostimulation, concomitant psychotherapy, and maintenance ketamine treatments.
• Markowitz et al. (2022) addressed the neglected role of psychotherapy in the treatment of treatment-resistant depression.

psilocybin

Psilocybin is related to psychotherapy as it is identified as a psychedelic substance utilized within therapeutic practices, as documented in the 2022 Frontiers in Psychology publication [1]. — 2 supporting facts

panpsychism

Panpsychism is related to psychotherapy because Robin S. Brown utilizes the concept as a theoretical framework to examine the relationship between 'inner' and 'outer' tropes in a clinical context, as stated in [1]. — 1 supporting fact